Literature DB >> 22024901

Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.

Jung-Shun Lee1, Cheng-Chang Yang, Yu-Min Kuo, Chun-I Sze, Jung-Yu C Hsu, Yi-Hung Huang, Shun-Fen Tzeng, Ching-Lin Tsai, Hsing-Hong Chen, I-Ming Jou.   

Abstract

STUDY
DESIGN: We used a severe contusive spinal cord injury (SCI) model and electrophysiologic, motor functional, immunohistochemical, and electron microscopic examinations to analyze the neuroprotective effects of delayed granulocyte colony-stimulating factor (G-CSF) treatment.
OBJECTIVE: To determine the neuroprotective effects of delayed G-CSF treatment using multimodality evaluations after severe contusive SCI in rats. SUMMARY OF BACKGROUND DATA: Despite some reports that G-CSF treatment in the acute stage of different central nervous system injury models was neuroprotective, it has not been determined whether delayed G-CSF treatment can promote neural recovery in severe contusive SCI.
METHODS: Rats with severe contusive SCI were divided into 2 groups: G-CSF group rats were given serial subcutaneous injections of G-CSF, and control group rats (controls) were given only saline injections on postcontusion days 9 to 13. Using the Basso-Beattie-Bresnahan scale and cortical somatosensory evoked potentials, we recorded functional evaluations weekly. The spinal cords were harvested for protein and immunohistochemical analysis, and for electron microscopy examination.
RESULTS: The preserved spinal cord area was larger in G-CSF group rats than in control group rats. Both sensory and motor functions improved after G-CSF treatment. Detachment and disruption of the myelin sheets in the myelinated axons were significantly decreased, and axons sprouted and regenerated. There were fewer microglia and macrophages in the G-CSF group than in the control group. The levels of brain-derived neurotrophic factor were comparable between the 2 groups.
CONCLUSION: Delayed G-CSF treatment at the subacute stage of severe contusive SCI promoted spinal cord preservation and improved functional outcomes. The mechanism of G-CSF's protection may be related in part to attenuating the infiltration of microglia and macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22024901     DOI: 10.1097/BRS.0b013e31823b0440

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.

Authors:  Mariama S Azmy; Esther T Menze; Reem N El-Naga; Mariane G Tadros
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 2.  Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.

Authors:  MirHojjat Khorasanizadeh; Mahsa Eskian; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 3.  Neutrophil contribution to spinal cord injury and repair.

Authors:  Virginie Neirinckx; Cécile Coste; Rachelle Franzen; André Gothot; Bernard Rogister; Sabine Wislet
Journal:  J Neuroinflammation       Date:  2014-08-28       Impact factor: 8.322

4.  Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury.

Authors:  William Gemio Jacobsen Teixeira; Alexandre Fogaça Cristante; Raphael Martus Marcon; Gustavo Bispo; Ricardo Ferreira; Tarcísio Eloy Pessoa de Barros-Filho
Journal:  Clinics (Sao Paulo)       Date:  2018-02-19       Impact factor: 2.365

5.  Anti-IL-20 antibody improved motor function and reduced glial scar formation after traumatic spinal cord injury in rats.

Authors:  Jung-Shun Lee; Yu-Hsiang Hsu; Yi-Shu Chiu; I-Ming Jou; Ming-Shi Chang
Journal:  J Neuroinflammation       Date:  2020-05-14       Impact factor: 8.322

6.  Mitochondrial Transplantation Attenuates Neural Damage and Improves Locomotor Function After Traumatic Spinal Cord Injury in Rats.

Authors:  Ming-Wei Lin; Shih-Yuan Fang; Jung-Yu C Hsu; Chih-Yuan Huang; Po-Hsuan Lee; Chi-Chen Huang; Hui-Fang Chen; Chen-Fuh Lam; Jung-Shun Lee
Journal:  Front Neurosci       Date:  2022-04-12       Impact factor: 4.677

7.  A scoping review of trials for cell-based therapies in human spinal cord injury.

Authors:  Alice G Willison; Sam Smith; Benjamin M Davies; Mark R N Kotter; Susan C Barnett
Journal:  Spinal Cord       Date:  2020-04-06       Impact factor: 2.772

8.  Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury.

Authors:  Gustavo Ferreira Simões; Alexandre Leite Rodrigues de Oliveira
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

9.  Level-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord Injury.

Authors:  James Hong; Alex Chang; Mohammad-Masoud Zavvarian; Jian Wang; Yang Liu; Michael G Fehlings
Journal:  Int J Mol Sci       Date:  2018-07-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.